Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.890
+0.080 (1.66%)
Dec 5, 2025, 4:00 PM EST - Market closed
Nyxoah Employees
Nyxoah had 184 employees as of December 31, 2024. The number of employees increased by 37 or 25.07% compared to the previous year.
Employees
184
Change (1Y)
37
Growth (1Y)
25.07%
Revenue / Employee
$36,036
Profits / Employee
-$535,019
Market Cap
214.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NYXH News
- 3 days ago - Publication relating to transparency notifications - GlobeNewsWire
- 8 days ago - Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 10 days ago - Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - GlobeNewsWire
- 15 days ago - Information on the total number of voting rights and shares - GlobeNewsWire
- 22 days ago - Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio - GlobeNewsWire
- 22 days ago - Nyxoah Reports Third Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 4 weeks ago - Nyxoah to Participate in the Stifel 2025 Healthcare Conference - GlobeNewsWire